- Mumbai's Neodocs secured $2 million in seed funding from investors, including Omidyar Network India and YCombinator.
- Neodocs aims to use the funds to expand its presence in international markets like Europe, Australia, and the US.
- The startup provides instant health test kits, including kidney care and UTI care kits.
Mumbai-based health-tech startup Neodocs has secured $2 million in seed funding from investors such as Omidyar Network India, YCombinator, 9Unicorns, Gemba Capital, and Titan Capital.
Additionally, angel investors including Kunal Shah from CRED, Varun Alagh from Mamaearth, Vivek Gambhir from Boat, and Harshad Reddy from Apollo Hospital also participated in the funding round.
With this funding, Neodocs plans to expand its presence in global markets like Europe, Australia, the Middle East, and the US. The startup, founded in 2020 by Nikunj Malpani, Anurag Meena, and Pratik Lodha, offers health test kits that allow users to take a test, take a picture, and receive instant results on their smartphones.
They have already launched two urine test kits, the kidney care kit, and the UTI care kit, which help measure various parameters related to kidney health and urinary tract infections.
Neodocs is also collaborating with renowned pharmaceutical companies like Cipla, Eris, Sun Pharma, AstraZeneca, Bayer, and RPG Life Sciences.
Edited by Shruti Thapa